| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e151409d8728dce91ff14e66973652fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a0f557b5db9643766b86720d359ebc64 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate |
1998-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3de410e7ff9b5d3fbaf1f4e6dbd7daa2 |
| publicationDate |
1999-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9917803-A1 |
| titleOfInvention |
Compositon for the treatment of nicotine addiction containing a nicotine receptor antagonist and an anti-depressant or anti-anxiety drug |
| abstract |
The present invention encompasses methods of treating patients for tobacco addiction and nicotine addiction, for palliating the effects of nicotine withdrawal, for providing or facilitating the effects of smoking cessation therapies and as long-term smoking cessation maintenance therapy. The invention also includes related pharmaceutical compositions comprising nicotine receptor antagonists and either an anti-depressant or an anti-anxiety drug. Specific combinations of drugs (mecamylamine HC1 and bupropion HC1) as well as mecamylamine in combination with certain drug classes (e.g., anti-anxiety drugs and anti-depressants) comprise the pharmaceutical compositions disclosed. These compositions are also contemplated for use in the treatment of cocaine addiction and the treatment of alcohol dependence. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8187607-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20010050225-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008038155-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6932971-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7452541-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02060425-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004096200-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6780871-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005067909-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008038155-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2392345-A2 |
| priorityDate |
1997-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |